Clinical Study
Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax
Table 1
Baseline demographic characteristics of the patients enrolled in the study.
| PQ regimens | Group A (no PQ) | Group B (15 mg/day × 14 days) | Group C (30 mg/day × 7 days) | Group D (30 mg/day × 14 days) |
| Number of patients enrolled | 397 | 398 | 381 | 380 | Total drop outs | 92 (23.1%) | 76 (19%) | 83 (21.7%) | 63 (16.5%) | Number of patients who completed 6 months of followup | 305 | 322 | 298 | 317 | Age in years (mean ± SD) | 18–76 (30 ± 14) | 18–76 (31 ± 12) | 18–74 (32 ± 13) | 18–70 (32 ± 11) | Gender | | | | | Male | 374 | 378 | 364 | 365 | Female | 23 | 20 | 17 | 15 | Parasitemia | 120–16780/L | 160–17600/L | 175–15620/L | 105–19239/L |
|
|